Relative survival | Cause-specific | Competing (due to cancers) | Competing (other death) | |
---|---|---|---|---|
HR (95% CI)b | HR (95% CI) | SHR (95% CI) | SHR (95% CI) | |
Indigenousc | ||||
1st year after diagnosis | 2.15 (1.96–2.36) | 2.17 (1.98–2.38) | 1.97 (1.79–2.17) | 1.67 (1.16–2.42) |
2nd year after diagnosis | 1.35 (1.11–1.64) | 1.47 (1.22–1.76) | 1.53 (1.27–1.85) | 2.75 (1.57–4.81) |
3rd year after diagnosis | 1.09 (0.79–1.52) | 1.32 (1.01–1.72) | 1.45 (1.11–1.90) | 5.10 (2.89–8.99) |
4th year after diagnosis | 1.29 (0.83–1.99) | 1.26 (0.87–1.80) | 1.44 (1.00–2.08) | 8.96 (4.60–17.47) |
5th year after diagnosis | 0.56 (0.25–1.28) | 0.78 (0.46–1.32) | 0.95 (0.56–1.62) | 5.72 (2.75–11.88) |
Female vs male | 0.83 (0.77–0.90) | 0.84 (0.78–0.90) | 0.85 (0.78–0.92) | 0.71 (0.54–0.93) |
Age at diagnosisd | ||||
Non-Indigenous | 1.03 (1.03–1.03) | 1.03 (1.03–1.03) | 1.03 (1.02–1.03) | 1.07 (1.06–1.08) |
Indigenous | 1.02 (1.01–1.02) | 1.01 (1.01–1.02) | 1.01 (1.00–1.02) | 1.05 (1.03–1.07) |